FDA oncology division director
Executive Summary
FDA appoints Robert Justice as director of the Division of Drug Oncology Products within FDA's Office of Oncology Drug Products, effective June 11. Justice had been acting director of the division since it became operational as part of a July 2005 CDER reorganization (1"The Pink Sheet" June 27, 2005, p. 11). Justice has held several positions within the agency since 1985 and was a senior clinical scientist at Genentech from 2000-2002...